Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Krawczynski; Krzysztof Z.
Address:
Tucker, GA
No. of patents:
7
Patents:












Patent Number Title Of Patent Date Issued
6455492 Hepatitis E virus vaccine and method September 24, 2002
Antigen and antibody vaccine composition effective in preventing hepatitis E virus (HEV) infection are disclosed. The antigen composition includes peptides corresponding to carboxyl terminal end regions of the second and third open reasing frames of the HEV genome. The composition is eff
6379891 Method of detecting HEV infection April 30, 2002
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic
6120988 Method of detecting hev infection September 19, 2000
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic
5824649 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic ep October 20, 1998
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic
5789559 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent August 4, 1998
Nucleic acid sequences derived from enterically transmitted nonA/nonB viral hepatitis agent (HEV) are disclosed. DNA sequences encoding specific epitopes within viral protein sequences that are reactive with sera of individuals infected with different strains of HEV are also disclosed.
5770689 Hepatitis E virus ORF Z peptides June 23, 1998
An antigen composition hepatitis E virus (HEV) infection are disclosed. The antigen composition includes peptides corresponding to carboxyl terminal end regions of the second and third open reading frames of the HEV genome.
5741490 Hepatitis E virus vaccine and method April 21, 1998
Antigen and antibody vaccine composition effective in preventing hepatitis E virus (HEV) infection are disclosed. The antigen composition includes a peptide corresponding to a carboxyl terminal end region of the capsid protein encoded by the second open reading frame 2 of the HEV genome.










 
 
  Recently Added Patents
Adaptive input interface
Systems and methods for performing live chat functionality via a mobile device
Dynamic web page construction based on determination of client device location
Resistive memory element sensing using averaging
Method for forming pattern
Fire detector
Microcapsules, their use and processes for their manufacture
  Randomly Featured Patents
Interface layer for navigation system
External actuating mechanism for vehicle locks
Liquid polyalkene in thermoplastic elastomer sealant formulation
Image forming apparatus with detecting members for determining when set width is wrong
Printing apparatus
Coreopsis plant named `RP #5`
Dispersion compensation in optical systems
Ratchetting pipe wrench
Controlled COF films
Device for identifying objects